Effect of Paricalcitol on Circulating Parathyroid Hormone in X-Linked Hypophosphatemia: A Randomized, Double-Blind, Placebo-Controlled Study | Zendy

Thomas O. Carpenter | Zendy; Elizabeth Olear | Zendy; Jane H. Zhang | Zendy; Bruce Ellis | Zendy; Christine Simpson | Zendy; David Cheng | Zendy; Caren M. Gundberg | Zendy; Karl Insogna | Zendy

Open Access

Effect of Paricalcitol on Circulating Parathyroid Hormone in X-Linked Hypophosphatemia: A Randomized, Double-Blind, Placebo-Controlled Study

Author(s) -

Thomas O. Carpenter,

Elizabeth Olear,

Jane H. Zhang,

Bruce Ellis,

Christine Simpson,

David Cheng,

Caren M. Gundberg,

Karl Insogna

Publication year - 2014

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-2017

Subject(s) - paricalcitol , medicine , placebo , hypophosphatemia , endocrinology , parathyroid hormone , secondary hyperparathyroidism , hyperparathyroidism , renal function , urology , calcium , pathology , alternative medicine

Hyperparathyroidism occurs frequently in X-linked hypophosphatemia (XLH) and may exacerbate phosphaturia, potentially affecting skeletal abnormalities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research